Sanara Medtech
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $26,305 | $21,671 | $20,158 | $18,536 |
Gross Profit | 24,056 | 19,679 | 18,150 | 15,541 |
EBITDA | 1,196 | -851 | -1,779 | -426 |
EBIT | -411 | -1,955 | -2,884 | -1,531 |
Net Income | -1,538 | -2,857 | -3,504 | -1,764 |
Net Change In Cash | 26,305 | 21,671 | 20,158 | 18,536 |
Free Cash Flow | 836 | 2,041 | -1,470 | -1,660 |
Cash | 15,878 | 16,277 | 6,150 | 2,828 |
Basic Shares | 8,531 | 8,517 | 8,468 | 8,419 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $86,672 | $64,989 | $45,842 | $24,143 |
Gross Profit | 78,532 | 57,137 | 39,481 | 21,832 |
EBITDA | -1,860 | -289 | -11,850 | -7,221 |
EBIT | -6,783 | -3,964 | -14,485 | -7,993 |
Net Income | -9,664 | -4,303 | -8,092 | -7,305 |
Net Change In Cash | 86,672 | 64,989 | 45,842 | 24,143 |
Cost of Revenue | -9,693 | |||
Free Cash Flow | -229 | -3,510 | -6,301 | -5,564 |
Cash | 15,878 | 5,147 | 8,958 | 18,652 |
Basic Shares | 8,484 | 8,278 | 7,906 | 7,341 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | -$0.18 |
2024-09-30 | -$0.34 |
2024-06-30 | -$0.41 |
2024-03-31 | -$0.21 |
